02 December 2024
SOLASTA Bio raises $14m, plans to commercialize peptide-based biopesticides in ‘half the time’ it takes for synthetics
UK-based ag biotech startup SOLASTA Bio has closed a $14 million oversubscribed Series A round, bringing its total funding to $19 million
SOLASTA Bio raises $14m for peptide-based biopesticides: SOLASTA Bio raises $14m, plans to commercialize peptide-based biopesticides in ‘half the time’ it takes for syntheticsMore articles
22 October 2025
ABIM 2025 Workshop: Peptide Regulation
Basel, Switzerland: SOLASTA's Chief Strategy Officer, Paula Pinto; Panelist at Annual Biocontrol Industry Meeting 2025 Peptide Regulation Session International Biocontrol Manufacturers Association (IBMA) is actively engaged in promoting innovative biocontrol solutions, ...
20 June 2025
BBSRC Impact Showcase 2025 – SOLASTA Bio Feature
In 2019, Professor Shireen Davies, SOLASTA® Bio’s CEO, was awarded a Biotechnology and Biological Research Council (BBSRC) Royal Society of Edinburgh Enterprise Fellowship. This provided support for the commercialisation of ...